SAN JOSE, Calif., May 14, 2025 /PRNewswire/ --News Summary: Product orders up 20% year over year; up 9% excluding Splunk, with growth across all geographies and customer markets AI Infrastructure orders taken from webscale customers exceeded $600 million, surpassing our $1 billion target one quarter early Revenue of $14.1 billion, up 11% year over year, above the high end of our guidance range Strong profitability with GAAP and non-GAAP margins and EPS above the high end of our guidance range Q3 FY 2025 Res ...

Advancing IKT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial HypertensionBOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension (“PAH”), today reported financial results for the quarter ended March 31, 2025 and highlighted recent developments. “During our first quarter of 2025, we co ...

Company expects its products to be in 30,000 U.S. and Canadian homes by the end of the Second quarter of 2025. Company is Progressing with Significant Projects and Orders that will Enable it to Become Cash Flow Positive in Second Half of 2025 General and Administrative Expenses Decreased by 17% as Compared to the First Quarter of 2024 and Gross Margin and Gross Profit Improvement by 4.8% and 2% in the First Quarter of 2025 Sequentially from the Fourth Quarter of 2024 SKYX Announces Additional $4 million in ...

LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Toro Corp. (NASDAQ: TORO) (“Toro”, or the “Company”), an international energy transportation services company, announces that on May 5, 2025, the senior term loan facility granted to Castor Maritime Inc. in December 2024 was fully repaid. About Toro Corp. Toro Corp. is an international energy transportation services company with a fleet of LPG carriers that carry liquefied petrochemical gases worldwide. Toro Corp. currently owns a fleet of four 5,000 LPG c ...

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in adults with acute leukemia (AL) were selected for a poster presentation at the European Hematology Association (EHA) 2025 Congress, taking place June 12–15 in Milan, Italy. The presentation will highlight emerging safety, pharmacokinetics/pharmacodynamics ...

MELVILLE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its business. “We have continued to execute well across our business, including the achievement of key clinical program milestones, since the start of 2025,” said Lance Alstodt, the Comp ...

Challenge Study measured safety, efficacy against infection and symptomatic disease as well as viral shedding Machine learning analyses identified statistically significant correlates of protection and will be incorporated into the development of Vaxart’s second-generation norovirus vaccine candidate, which is being evaluated in a Phase 1 clinical trial SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the publication of complete data from a Phase 2b ...

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today reported financial results for the quarter ended March 31, 2025, and highlighted recent achievements and upcoming milestones. “We’re seeing strong momentum across our development programs, with our team continui ...

SUNNYVALE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- eGain (Nasdaq: EGAN), the AI knowledge management platform for service, today announced financial results for its fiscal 2025 third quarter ended March 31, 2025. “Our third quarter results exceeded expectations on profitability and delivered solid operating cash flow,” said Ashu Roy, eGain’s CEO. “Shortly after the quarter closed, we secured one of our largest expansion deals ever with a U.S. megabank. We also launched our AI Agent for Contact Center durin ...

LITTLE ROCK, Ark., May 14, 2025 (GLOBE NEWSWIRE) -- Dillard’s, Inc. (DDS: NYSE) will announce results for the 13 weeks ended May 3, 2025 tomorrow before the open of the New York Stock Exchange. Contact: Julie J. GuymonDirector of Investor Relations(501) 376-5965 julie.guymon@dillards.com ...